We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

002304:SZSEJiangsu Yanghe Distillery Co., Ltd. Analysis

Data as of 2026-06-10 - not real-time

CN¥43.35

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Jiangsu Yanghe is trading at CNY 43.35, barely above the computed support level of 41.80 and well below its 20‑day SMA of 44.39, signaling a bearish short‑term bias. Technical indicators reinforce this view: RSI sits at 39, MACD is in a bearish divergence and the price is trapped between the 20‑day and 50‑day moving averages, with the 200‑day SMA still far higher at 59.88. The stock’s volatility is elevated at roughly 26% over the past 30 days and it has suffered a steep max drawdown of 43%, indicating a risky price environment.
Fundamentally, the company faces serious headwinds: revenue fell 26% YoY, operating cash flow and free cash flow are negative, and earnings have collapsed, as highlighted by recent news of demand pressure and a sharp profit decline. While the dividend yield appears attractive at 11%, the payout ratio exceeds 300%, making the dividend unsustainable. Valuation metrics are mixed – a trailing P/E of 63.7 looks expensive, yet a forward P/E of 15.5 suggests potential upside if earnings recover. The balance sheet is relatively sound with low debt, but the ongoing cash‑flow deficit and weak earnings growth raise concerns about long‑term profitability.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Price below key moving averages
  • Bearish MACD and RSI indicating momentum weakness
  • Proximity to support with limited upside

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Potential earnings turnaround reflected in forward P/E
  • High dividend yield offset by unsustainable payout
  • Continued revenue pressure and negative cash flow

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong gross margin and low leverage
  • Forward valuation suggests upside if profitability recovers
  • Defensive consumer sector positioning

Key Metrics & Analysis

Financial Health

Revenue Growth-26.00%
Profit Margin6.22%
P/E Ratio63.7
ROE1.98%
ROA1.67%
Debt/Equity0.43
P/B Ratio1.3
Op. Cash FlowCN¥-1360069632
Free Cash FlowCN¥-1973422080

Technical Analysis

TrendBearish
RSI39.4
SupportCN¥41.80
ResistanceCN¥48.15
MA 20CN¥44.39
MA 50CN¥47.63
MA 200CN¥59.88
MACDBearish
VolumeStable
Fear & Greed Index85.95

Valuation

Target PriceCN¥56.11
Upside/Downside29.44%
GradeFair
TypeValue
Dividend Yield11.07%

Risk Assessment

Beta-0.03
Volatility25.76%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.